BlackRock, Inc. 13D and 13G filings for Alaunos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-07-08 4:56 pm Sale |
2022-06-30 | 13G | Alaunos Therapeutics, Inc. TCRT |
BLACKROCK INC BLK |
34,919 2.400% |
-76,848 (-68.76%) |
Filing |
| 2022-02-02 7:11 pm Sale |
2021-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT |
BLACKROCK INC BLK |
111,766 7.800% |
-11,969 (-9.67%) |
Filing |
| 2021-02-01 08:23 am Purchase |
2020-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT |
BLACKROCK INC BLK |
123,736 8.700% |
40,457 (+48.58%) |
Filing |